Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications

Published:2021-09-15 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Agusti Alvar¹,Fabbri Leonardo²,Lahousse Lies³,Singh Dave⁴,Papi Alberto⁵^ORCID

Affiliation:

1. Respiratory Institute IDIBAPS CIBERES Hospital ClinicUniv. Barcelona Barcelona Spain

2. Section of Respiratory Medicine Department of Morphology, Surgery and Experimental Medicine University of Ferrara Ferrara Italy

3. Department of Bioanalysis Ghent University Ghent Belgium

4. Medicines Evaluation Unit University of ManchesterManchester University NHS Foundation Trust Manchester UK

5. Emergency Department, Respiratory Medicine University of FerraraUniversity Hospital S. Anna Ferrara Italy

Funder

Chiesi Farmaceutici

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15076

Reference52 articles.

1. Global strategy for asthma management and prevention (GINA).2021;https://ginasthma.org/. Accessed April 26 2021.

2. Triple therapy in a single inhaler: a new option for uncontrolled asthma

3. Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy

4. Minimal clinically important difference for asthma endpoints: an expert consensus report

5. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinician’s guide to single vs multiple inhaler therapy for COPD;Expert Review of Respiratory Medicine;2024-07-02

2. Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement;Expert Opinion on Pharmacotherapy;2024-05-23

3. The pharmacological management of asthma in adults: 2023 update;Expert Opinion on Pharmacotherapy;2024-03-03

4. Current pharmacotherapy of COPD;COPD in the 21st Century;2024-03-01

5. Real-World Users of Triple Therapy for Asthma in the US;The American Journal of Managed Care;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3